Return to study ST001157 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
glycosyl ceramide (d16:1/24:1, d18:1/22:1) ME276170 HexCer 40:2;O2 --Reversed phase NEGATIVE ION MODE
glycosyl ceramide (d18:1/20:0, d16:1/22:0) ME276171 HexCer 38:1;O2 --Reversed phase NEGATIVE ION MODE
glycosyl ceramide (d18:1/23:1, d17:1/24:1) ME276172 HexCer 41:2;O2 --Reversed phase NEGATIVE ION MODE
glycosyl ceramide (d18:2/24:1, d18:1/24:2) ME276173 HexCer 42:3;O2 --Reversed phase NEGATIVE ION MODE
glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) ME276174 HexCer 18:2;O2/22:0 --Reversed phase NEGATIVE ION MODE
glycosyl-N-nervonoyl-sphingosine (d18:1/24:1) ME276175 HexCer 18:1;O2/24:1 --Reversed phase NEGATIVE ION MODE
glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) ME276176 HexCer 18:1;O2/16:0 --Reversed phase NEGATIVE ION MODE
glycosyl-N-stearoyl-sphingosine (d18:1/18:0) ME276177 HexCer 18:1;O2/18:0 --Reversed phase NEGATIVE ION MODE
lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) ME276231 LacCer 18:1;O2/16:0 --Reversed phase NEGATIVE ION MODE


  logo